You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 5, February 1, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  NIH Consensus Conference
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (367)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

Larry C. Gilstrap, MD; Robert Christensen, MD; William H. Clewell, MD; Mary E. D'Alton, MD; Ezra C. Davidson, Jr, MD; Marilyn B. Escobedo, MD; Dwenda K. Gjerdingen, MD; Jan Goddard-Finegold, MD; Robert L. Goldenberg, MD; David A. Grimes, MD; Thomas N. Hansen, MD; Ralph E. Kauffman, MD; Emmett B. Keeler, PhD; William Oh, MD; Elizabeth J. Susman, PhD, RN; Marlyn G. Vogel, EdD; Mary Ellen Avery, MD; Philip L. Ballard, MD, PhD; Roberta A. Ballard, MD; Patricia Crowley, MRCOG, FRCPI; Marilyn B. Escobedo, MD; Thomas Garite, MD; Robert L. Goldenberg, MD; Gary D.V. Hankins, MD; Alan H. Jobe, MD, PhD; Ralph E. Kauffman, MD; Janna G. Koppe, MD, PhD; James E. Maher, MD; Irwin R. Merkatz, MD; Seetha Shankaran, MD; Kit N. Simpson, DrPH; John C. Sinclair, MD; Theodore A. Slotkin, PhD; H. William Taeusch, Jr, MD; Linda L. Wright, MD; Duane Alexander, MD; Roberta A. Ballard, MD; Mary Anne Berberich, PhD; Michael Bracken, PhD; Leslie Cooper, PhD; Larry Culpepper, MD, MPH; Jerry M. Elliott; John H. Ferguson, MD; Frederic Frigoletto, MD; Dorothy Berlin Gail, PhD; Larry C. Gilstrap, MD; William H. Hall; Alan H. Jobe, MD, PhD; M. Douglas Jones, Jr, MD; Barbara Medoff-Cooper, PhD; Gerald B. Merenstein, MD; Judith M. Whalen, MPA; Linda L. Wright, MD; John H. Ferguson, MD; Claude Lenfant, MD; Ada Sue Hinshaw, PhD, RN

JAMA. 1995;273(5):413-418.


Abstract

Objective.
—To develop a consensus on the use of antenatal corticosteroids for fetal maturation in preterm infants.

Participants.
—A nonfederal, nonadvocate, 16-member consensus panel including representatives from neonatology, obstetrics, family medicine, behavioral medicine, psychology, biostatistics, and the public; 19 experts in neonatology, obstetrics, and pharmacology presented data to the consensus panel and a conference audience of approximately 500.

Evidence.
—An extensive bibliography of references was produced for the consensus panel and the conference audience using a variety of on-line databases including MEDLINE. The consensus panel met several times prior to the conference to review the literature. It also commissioned an updated meta-analysis, a neonatal registry review, and an economic analysis that were presented at the conference. The experts prepared abstracts for distribution at the conference, presented data, and answered questions from the panel and audience. The panel evaluated the strength of the scientific evidence using the grading system developed by the Canadian Task Force on the Periodic Health Examination and adapted by the US Preventive Services Task Force.

Consensus.
—The consensus panel, answering predefined consensus questions, developed their conclusions based on the scientific evidence presented in open forum and the scientific literature.

Consensus Statement.
—The consensus panel composed a draft statement that was read in its entirety at the conference for comment. The panel released a revised statement at the end of the conference and finalized the revisions a few weeks after the conference.

Conclusions.
—Antenatal corticosteroid therapy is indicated for women at risk of premature delivery with few exceptions and will result in a substantial decrease in neonatal morbidity and mortality, as well as substantial savings in health care costs. The use of antenatal corticosteroids for fetal maturation is a rare example of a technology that yields substantial cost savings in addition to improving health.

(JAMA. 1995;273:413-418)



Author Affiliations

Panel, and Conference Chairperson, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas; Professor and Chief, Neonatology/Pediatrics, University of Florida College of Medicine, Gainesville; Associate Director, Department of Maternal-Fetal Medicine, Phoenix Perinatal Associates, Phoenix, Ariz; Chief of Obstetrics and Maternal Fetal Medicine, Department of Obstetrics and Gynecology, New England Medical Center-Tufts University, Boston, Mass; Professor and Chairman of Obstetrics and Gynecology, Martin Luther King, Jr/Charles R. Drew University, Los Angeles, Calif; Professor of Pediatrics, Director, Division of Neonatology, University of Texas Health Sciences Center, San Antonio; Associate Professor, Department of Family Practice and Community Health, University of Minnesota, Saint Paul; Associate Professor, Department of Pediatrics and Pathology, Division of Pediatric Neurology, Baylor College of Medicine, Houston, Tex; Director of the Center for Obstetric Research, Professor, Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine; Professor, Department of Obstetrics and Gynecology, University of California at San Francisco, San Francisco General Hospital; Professor, Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Professor, Department of Pediatrics and Pharmacology, Wayne State University, Children's Hospital of Michigan, Detroit; Senior Mathematician, Department of Social Policy, RAND, Santa Monica, Calif; Professor and Chair, Department of Pediatrics, Brown University School of Medicine, Women and Infants Hospital, Providence, RI; Professor, Biobehavioral Health Program, The Pennsylvania State University, University Park; Psychologist, School District of Hatboro Horsham, Elkins Park, Pa; Planning Committee Chairperson, Director, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md; Professor of Pediatrics, Obstetrics, and Gynecology, Chief, Division of Neonatology, Department of Pediatrics, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia (Pa); Health Sciences Administrator, Cell and Developmental Biology Branch, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Professor and Vice Chairman, Department of Epidemiology and Public Health, Yale University, New Haven, Conn; Nurse Epidemiologist, Division of Extramural Programs, National Institute of Nursing Research, National Institutes of Health, Bethesda, Md; Research Director, Department of Family Medicine, Brown University Memorial Hospital of Rhode Island, Pawtucket; Program Analyst, Office of Medical Applications of Research, National Institutes of Health, Bethesda, Md; Director, Office of Medical Applications of Research, National Institutes of Health, Bethesda, Md; Chief of Vincent Memorial Obstetrics Division, Massachusetts General Hospital, Boston; Chief, Cell and Developmental Biology Branch, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Professor, Department of Obstetrics and Gynecology, University of Texas, Southwestern Medical Center, Dallas; Director of Communications, Office of Medical Applications of Research, National Institutes of Health, Bethesda, Md; Professor of Pediatrics-Neonatology, Director, Walter P. Martin Research Center, Harbor-UCLA Medical Center, UCLA School of Medicine, Torrance, Calif; Chairman, Department of Pediatrics, University of Colorado School of Medicine, Pediatrician-in-Chief, The Children's Hospital, Denver; Associate Professor, University of Pennsylvania School of Nursing, Philadelphia; Professor, Department of Pediatrics, University of Colorado School of Medicine/The Children's Hospital, Denver; Chief, Office of Science Policy and Analysis, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md; Special Assistant to the Director, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md; Office of Medical Applications of Research; Director; National Heart, Lung, and Blood Institute; Director; National Institute of Nursing Research; Director


Footnotes

NIH Consensus Development Conferences are convened to evaluate available scientific information and to resolve safety and efficacy issues related to a biomedical technology. The resultant NIH Consensus Statements are intended to advance understanding of the technology or issue in question and to be useful to health professionals and the public.

NIH Consensus Statements are prepared by a nonadvocate, nonfederal panel of experts based on (1) presentations by investigators working in areas relevant to the consensus questions during a 2-day public session; (2) questions and statements from conference attendees during open discussion periods that are part of the public session; and (3) closed deliberations by the panel during the remainder of the second day and morning of the third day. This statement is an independent report of the panel and is not a policy statement of the NIH or the federal government.

Preparation and distribution of this statement is the responsibility of the Office of Medical Applications of Research of the National Institutes of Health. Free copies of this statement and bibliographies prepared by the National Library of Medicine are available from the Office of Medical Applications of Research, Federal Bldg, Room 618, National Institutes of Health, 7550 Wisconsin Ave MSC 9120, Bethesda, MD 20892 (William H. Hall), or the NIH Consensus Program Information Service by 24-hour voice mail at (800) NIH-OMAR (644-6627).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Maternal Dexamethasone Treatment in Early Pregnancy on Pituitary-Adrenal Axis in Fetal Sheep
Braun et al.
Endocrinology 2009;150:5466-5477.
ABSTRACT | FULL TEXT  

Na +,K+-ATPase Activity and Subunit Isoform Protein Abundance: Effects of Antenatal Glucocorticoids in the Frontal Cerebral Cortex and Renal Cortex of Ovine Fetuses
Mehter et al.
Reproductive Sciences 2009;16:294-307.
ABSTRACT  

Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep
Tang et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R309-R317.
ABSTRACT | FULL TEXT  

Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension
Shaltout et al.
Hypertension 2009;53:404-408.
ABSTRACT | FULL TEXT  

Single versus multiple antenatal steroids in threatened preterm delivery: more benefit or harm?
Belteki and Smith
Arch. Dis. Child. Fetal Neonatal Ed. 2009;94:5-7.
FULL TEXT  

Disrupted secretory activation of the mammary gland after antenatal glucocorticoid treatment in sheep
Henderson et al.
Reproduction 2008;136:649-655.
ABSTRACT | FULL TEXT  

Plasma and Renal Renin Concentrations in Adult Sheep After Prenatal Betamethasone Exposure
Kantorowicz et al.
Reproductive Sciences 2008;15:831-838.
ABSTRACT  

Pregnancy after Kidney Transplantation
McKay and Josephson
CJASN 2008;3:S117-S125.
ABSTRACT | FULL TEXT  

Long-Term Outcomes after Repeat Doses of Antenatal Corticosteroids
Wapner et al.
NEJM 2007;357:1190-1198.
ABSTRACT | FULL TEXT  

Prenatal Corticosteroids -- Early Gain, Long-Term Questions
Stiles
NEJM 2007;357:1248-1250.
FULL TEXT  

"Masculinizing" Effect on Respiratory Morbidity in Girls From Unlike-Sex Preterm Twins: A Possible Transchorionic Paracrine Effect
Shinwell et al.
Pediatrics 2007;120:e447-e453.
ABSTRACT | FULL TEXT  

Level and Volume of Neonatal Intensive Care and Mortality in Very-Low-Birth-Weight Infants
Phibbs et al.
NEJM 2007;356:2165-2175.
ABSTRACT | FULL TEXT  

Low birth weight in the United States
Goldenberg and Culhane
Am. J. Clin. Nutr. 2007;85:584S-590S.
ABSTRACT | FULL TEXT  

Randomized Trial of a Single Repeat Dose of Prenatal Betamethasone Treatment in Imminent Preterm Birth
Peltoniemi et al.
Pediatrics 2007;119:290-298.
ABSTRACT | FULL TEXT  

Effects of dexamethasone on the glucogenic capacity of fetal, pregnant, and non-pregnant adult sheep
Franko et al.
J Endocrinol 2007;192:67-73.
ABSTRACT | FULL TEXT  

Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition
Patel et al.
Proc. Natl. Acad. Sci. USA 2006;103:18668-18673.
ABSTRACT | FULL TEXT  

ErbB receptor regulation by dexamethasone in mouse type II epithelial cells
Dammann et al.
Eur Respir J 2006;28:1117-1123.
ABSTRACT | FULL TEXT  

Skeletal muscle glucose transporter protein responses to antenatal glucocorticoids in the ovine fetus.
Gray et al.
J Endocrinol 2006;189:219-229.
ABSTRACT | FULL TEXT  

Effects of Multiple Courses of Antenatal Corticosteroids on Blood-Brain Barrier Permeability in the Ovine Fetus
Sadowska et al.
Reproductive Sciences 2006;13:248-255.
ABSTRACT  

Adverse Neonatal Outcomes Associated With Antenatal Dexamethasone Versus Antenatal Betamethasone
Lee et al.
Pediatrics 2006;117:1503-1510.
ABSTRACT | FULL TEXT  

Acute and Long-Term Effects of Clinical Doses of Antenatal Glucocorticoids in the Developing Fetal Sheep Kidney
Massmann et al.
Reproductive Sciences 2006;13:174-180.
ABSTRACT  

Modeling Glucocorticoid-Mediated Fetal Lung Maturation: I. Temporal Patterns of Corticosteroids in Rat Pregnancy
Samtani et al.
J. Pharmacol. Exp. Ther. 2006;317:117-126.
ABSTRACT | FULL TEXT  

Modeling Glucocorticoid-Mediated Fetal Lung Maturation: II. Temporal Patterns of Gene Expression in Fetal Rat Lung
Samtani et al.
J. Pharmacol. Exp. Ther. 2006;317:127-138.
ABSTRACT | FULL TEXT  

11beta-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites
Garbrecht et al.
Am. J. Physiol. Endocrinol. Metab. 2006;290:E653-E660.
ABSTRACT | FULL TEXT  

Cardiac effects of a single course of antenatal betamethasone in preterm infants
Vural et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2006;91:F118-F122.
ABSTRACT | FULL TEXT  

Mortality Among Very Low-Birthweight Infants in Hospitals Serving Minority Populations
Morales et al.
AJPH 2005;95:2206-2212.
ABSTRACT | FULL TEXT  

Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants <32 Weeks' Gestation Between 1993 and 1998
Vohr et al.
Pediatrics 2005;116:635-643.
ABSTRACT | FULL TEXT  

Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep
Jellyman et al.
J. Physiol. 2005;567:673-688.
ABSTRACT | FULL TEXT  

BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USE
Samtani et al.
Drug Metab. Dispos. 2005;33:1124-1130.
ABSTRACT | FULL TEXT  

From the Archives of the AFIP: Lung Disease in Premature Neonates: Radiologic-Pathologic Correlation
Agrons et al.
RadioGraphics 2005;25:1047-1073.
ABSTRACT | FULL TEXT  

Inhaled Nitric Oxide Therapy in the Preterm Infant Who Has Respiratory Distress Syndrome
Van Meurs
NeoReviews 2005;6:e268-e277.
FULL TEXT  

Genes Involved in the Adrenal Pathway of Glucocorticoid Synthesis Are Transiently Expressed in the Developing Lung
Provost and Tremblay
Endocrinology 2005;146:2239-2245.
ABSTRACT | FULL TEXT  

Morphine, Hypotension, and Adverse Outcomes Among Preterm Neonates: Who's to Blame? Secondary Results From the NEOPAIN Trial
Hall et al.
Pediatrics 2005;115:1351-1359.
ABSTRACT | FULL TEXT  

Executive Summary of the Workshop on the Border of Viability
Higgins et al.
Pediatrics 2005;115:1392-1396.
ABSTRACT | FULL TEXT  

Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary-adrenal axis
Lohle et al.
J. Physiol. 2005;564:575-588.
ABSTRACT | FULL TEXT  

Rehospitalisation after birth hospitalisation: patterns among infants of all gestations
Escobar et al.
Arch. Dis. Child. 2005;90:125-131.
ABSTRACT | FULL TEXT  

Follow-up Care of High-Risk Infants
Pediatrics 2004;114:1377-1397.
ABSTRACT | FULL TEXT  

Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial
Sandri et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2004;89:F394-F398.
ABSTRACT | FULL TEXT  

A Link between Lung Androgen Metabolism and the Emergence of Mature Epithelial Type II Cells
Provost et al.
Am. J. Respir. Crit. Care Med. 2004;170:296-305.
ABSTRACT | FULL TEXT  

Bias in Reported Neurodevelopmental Outcomes Among Extremely Low Birth Weight Survivors
Castro et al.
Pediatrics 2004;114:404-410.
ABSTRACT | FULL TEXT  

Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs
Banjanin et al.
J. Physiol. 2004;558:305-318.
ABSTRACT | FULL TEXT  

Timing of Initial Surfactant Treatment for Infants 23 to 29 Weeks' Gestation: Is Routine Practice Evidence Based?
Horbar et al.
Pediatrics 2004;113:1593-1602.
ABSTRACT | FULL TEXT  

Developmental regulation of the 5-HT7 serotonin receptor and transcription factor NGFI-A in the fetal guinea-pig limbic system: influence of GCs
Andrews et al.
J. Physiol. 2004;555:659-670.
ABSTRACT | FULL TEXT  

Resolving Our Uncertainty About Oxygen Therapy
Cole et al.
Pediatrics 2003;112:1415-1419.
FULL TEXT  

Microarray Analysis of Uterine Gene Expression in Mouse and Human Pregnancy
Bethin et al.
Mol. Endocrinol. 2003;17:1454-1469.
ABSTRACT | FULL TEXT  

Maternal Glucocorticoid Supplementation and S100B Protein Concentrations in Cord Blood and Urine of Preterm Infants
Gazzolo et al.
Clin. Chem. 2003;49:1215-1218.
FULL TEXT  

Ectopic expression of Kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier
Jaubert et al.
Development 2003;130:2767-2777.
ABSTRACT | FULL TEXT  

Fetal exposure to corticosteroids: how low can we go?
Nijland
J. Physiol. 2003;549:1-1.
FULL TEXT  

Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep
Molnar et al.
J. Physiol. 2003;547:61-66.
ABSTRACT | FULL TEXT  

Prenatal Dexamethasone Programs Hypertension and Renal Injury in the Rat
Ortiz et al.
Hypertension 2003;41:328-334.
ABSTRACT | FULL TEXT  

Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries
Hai et al.
Am. J. Physiol. Heart Circ. Physiol. 2002;283:H1743-H1749.
ABSTRACT | FULL TEXT  

Risks to the children born to mothers with autoimmune diseases
Scott
Lupus 2002;11:655-660.
ABSTRACT  

Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep
Molnar et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;283:R561-R567.
ABSTRACT | FULL TEXT  

Trends in Mortality and Morbidity for Very Low Birth Weight Infants, 1991-1999
Horbar et al.
Pediatrics 2002;110:143-151.
ABSTRACT | FULL TEXT  

Pre- and Postnatal Lung Development, Maturation, and Plasticity : Suppression of cell proliferation and programmed cell death by dexamethasone during postnatal lung development
Luyet et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2002;282:L477-L483.
ABSTRACT | FULL TEXT  

Single vs Weekly Courses of Antenatal Corticosteroids for Women at Risk of Preterm Delivery: A Randomized Controlled Trial
Guinn et al.
JAMA 2001;286:1581-1587.
ABSTRACT | FULL TEXT  

Antenatal Corticosteroids--Too Much of a Good Thing?
Lawson
JAMA 2001;286:1628-1630.
FULL TEXT  

A Woman With an Extremely Premature Newborn
Richardson
JAMA 2001;286:1498-1505.
FULL TEXT  

Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1
Docherty et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001;281:R261-R268.
ABSTRACT | FULL TEXT  

Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997
Manktelow et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2001;85:F33-35.
ABSTRACT | FULL TEXT  

Urinary Leukotriene E4 Excretion During the First Month of Life and Subsequent Bronchopulmonary Dysplasia in Premature Infants
Sheikh et al.
Chest 2001;119:1749-1754.
ABSTRACT | FULL TEXT  

Is There a Role for Antioxidant Therapy in Bronchopulmonary Dysplasia?
Welty
J. Nutr. 2001;131:947S-950.
ABSTRACT | FULL TEXT  

Prospects for Research in Reproductive Health and Birth Outcomes
Goldenberg and Jobe
JAMA 2001;285:633-639.
ABSTRACT | FULL TEXT  

Effects of postnatal dexamethasone on blood-brain barrier permeability and brain water content in newborn lambs
Sysyn et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001;280:R547-R553.
ABSTRACT | FULL TEXT  

Endogenous Surfactant Turnover in Preterm Infants with Respiratory Distress Syndrome Studied with Stable Isotope Lipids
CAVICCHIOLI et al.
Am. J. Respir. Crit. Care Med. 2001;163:55-60.
ABSTRACT | FULL TEXT  

Effect of Dexamethasone Treatment on Maturational Changes in the NMDA Receptor in Sheep Brain
McGowan et al.
J. Neurosci. 2000;20:7424-7429.
ABSTRACT | FULL TEXT  

Effect of Prenatal Steroids on Potassium Balance in Extremely Low Birth Weight Neonates
Omar et al.
Pediatrics 2000;106:561-567.
ABSTRACT | FULL TEXT  

Antenatal steroids and the developing brain
Whitelaw and Thoresen
Arch. Dis. Child. Fetal Neonatal Ed. 2000;83:154F-157.
ABSTRACT | FULL TEXT  

Androgen Formation and Metabolism in the Pulmonary Epithelial Cell Line A549: Expression of 17{beta}-Hydroxysteroid Dehydrogenase Type 5 and 3{alpha}-Hydroxysteroid Dehydrogenase Type 3
Provost et al.
Endocrinology 2000;141:2786-2794.
ABSTRACT | FULL TEXT  

Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus
Stonestreet et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;279:R468-R477.
ABSTRACT | FULL TEXT  

Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse
Gross et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;278:R1415-R1423.
ABSTRACT | FULL TEXT  

Cell Type-Specific Regulation of Fetal Fibronectin Expression in Amnion: Conservation of Glucocorticoid Responsiveness in Human and Nonhuman Primates
Ma et al.
Biol. Reprod. 2000;62:1812-1817.
ABSTRACT | FULL TEXT  

Clinical Use of Antenatal Corticosteroids: Benefits and Risks
Merrill and Ballard
NeoReviews 2000;1:e91-98.
FULL TEXT  

Gene Knockout Mice in the Study of Parturitions
Gross et al.
Reproductive Sciences 2000;7:88-95.
ABSTRACT  

Mortality and Time to Death in Very Low Birth Weight Infants: California, 1987 and 1993
Gould et al.
Pediatrics 2000;105:37e-37.
ABSTRACT | FULL TEXT  

The Incidence of Necrotizing Enterocolitis After Introducing Standardized Feeding Schedules for Infants Between 1250 and 2500 Grams and Less Than 35 Weeks of Gestation
Kamitsuka et al.
Pediatrics 2000;105:379-384.
ABSTRACT | FULL TEXT  

Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs
Tan et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1999;277:L1142-L1148.
ABSTRACT | FULL TEXT  

Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud et al.
NEJM 1999;341:1190-1196.
ABSTRACT | FULL TEXT  

Effects of Prenatal Steroids on Water and Sodium Homeostasis in Extremely Low Birth Weight Neonates
Omar et al.
Pediatrics 1999;104:482-488.
ABSTRACT | FULL TEXT  

Na+-K+-ATPase gene regulation by glucocorticoids in a fetal lung epithelial cell line
Chalaka et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1999;277:L197-L203.
ABSTRACT | FULL TEXT  

Delivery Room Management of Extremely Low Birth Weight Infants: Spontaneous Breathing or Intubation?
Lindner et al.
Pediatrics 1999;103:961-967.
ABSTRACT | FULL TEXT  

Antenatal steroids decrease blood-brain barrier permeability in the ovine fetus
Stonestreet et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999;276:R283-R289.
ABSTRACT | FULL TEXT  

Methods to Encourage the Use of Antenatal Corticosteroid Therapy for Fetal Maturation: A Randomized Controlled Trial
Leviton et al.
JAMA 1999;281:46-52.
ABSTRACT | FULL TEXT  

Fetal Versus Maternal and Gestational Age Effects of Repetitive Antenatal Glucocorticoids
Jobe et al.
Pediatrics 1998;102:1116-1125.
ABSTRACT | FULL TEXT  

Declining Severity Adjusted Mortality: Evidence of Improving Neonatal Intensive Care
Richardson et al.
Pediatrics 1998;102:893-899.
ABSTRACT | FULL TEXT  

Neonatal Intensive Care Unit Report Cards
Perlman
Pediatrics 1998;102:975-976.
FULL TEXT  

Opposing actions of prostaglandins and oxytocin determine the onset of murine labor
Gross et al.
Proc. Natl. Acad. Sci. USA 1998;95:11875-11879.
ABSTRACT | FULL TEXT  

Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs
Walther et al.
J. Appl. Physiol. 1998;85:273-278.
ABSTRACT | FULL TEXT  

Comparison of Two Strategies for Surfactant Prophylaxis in Very Premature Infants: A Multicenter Randomized Trial
Kendig et al.
Pediatrics 1998;101:1006-1012.
ABSTRACT | FULL TEXT  

Antenatal Dexamethasone and Decreased Severity of Retinopathy of Prematurity
Higgins et al.
Arch Ophthalmol 1998;116:601-605.
ABSTRACT | FULL TEXT  

Direct fetal glucocorticoid treatment alters postnatal adaptation in premature newborn baboons
Ervin et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1998;274:R1169-R1176.
ABSTRACT | FULL TEXT  

Endogenous Surfactant Turnover in Preterm Infants Measured with Stable Isotopes
BUNT et al.
Am. J. Respir. Crit. Care Med. 1998;157:810-814.
ABSTRACT | FULL TEXT  

Antenatal Thyrotropin-Releasing Hormone to Prevent Lung Disease in Preterm Infants
Ballard et al.
NEJM 1998;338:493-498.
ABSTRACT | FULL TEXT  

Glucocorticoid Effects in the Human Placenta: Evidence That Dexamethasone-Mediated Inhibition of Fibronectin Expression in Cytotrophoblasts Involves a Protein Intermediate
Yoon et al.
J. Clin. Endocrinol. Metab. 1998;83:632-637.
ABSTRACT | FULL TEXT  

A Longitudinal Study of Developmental Outcome of Infants With Bronchopulmonary Dysplasia and Very Low Birth Weight
Singer et al.
Pediatrics 1997;100:987-993.
ABSTRACT | FULL TEXT  

Glucocorticoid regulation of surfactant components in immature lambs
Ballard et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1997;273:L1048-L1057.
ABSTRACT | FULL TEXT  

Repetitive Prenatal Glucocorticoids Improve Lung Function and Decrease Growth in Preterm Lambs
IKEGAMI et al.
Am. J. Respir. Crit. Care Med. 1997;156:178-184.
ABSTRACT | FULL TEXT  

Antenatal Phenobarbital Therapy and Neonatal Income
Thorp et al.
Pediatrics 1997;99:751-751.
FULL TEXT  

Neonatology
Gauda and Gleason
JAMA 1996;275:1823-1824.
ABSTRACT  

Corticosteroids for Fetal Maturation
Patterson
JAMA 1995;274:943-943.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.